© Reuters.
EDMONTON, AB – Aurora Cannabis Inc. (NASDAQ: NASDAQ:) (TSX: ACB), a leading global medical cannabis company based in Canada, has announced the repayment of roughly $7.2 million (US$5.3 million), which constitutes the final payment on the principal amount of its convertible senior notes. The total cash cost for this repayment, including accrued interest, was about $7.4 million (approximately US$5.5 million). With this move, Aurora has now settled nearly $465 million in convertible debt, leaving the company with a remaining debt of $47.9 million related to Bevo Farms Ltd.
Miguel Martin, CEO of Aurora, expressed that this repayment is a “significant milestone,” highlighting the company’s commitment to balance sheet strength and financial discipline. Martin anticipates these efforts will contribute to Aurora achieving its goal of positive free cash flow within the current calendar year.
Aurora Cannabis, with…
